스마트 흡입기 시장 : 제품별, 판매 채널별, 지역별

Smart Inhalers Market is estimated to be valued at USD 1488.3 Mn in 2026 and is expected to reach USD 37,567.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 58.6% from 2026 to 2033.

A smart inhaler is a medical device that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use.

Market Dynamics

Rise in prevalence of respiratory disorders, growing geriatric (aging) population around the world, the outbreak of COVID-19 across the globe, and increasing demand/adoption of smart inhalers are major factors expected to drive growth of the global smart inhalers market. For instance, In January 2023, Aseptika won an Innovate UK Smart Award to develop a Smart Inhaler Tracker for patients with lung health conditions. The Smart Award will help the company develop its third-generation smart inhaler tracker, which will have 5G mobile connectivity built-in. This means that patients will no longer have to send their data via a smartphone to their clinical teams, carers, or parent; it will just send information over the airwaves directly to the company's cloud databases.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global smart inhalers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Adherium Limited, AstraZeneca, Boehringer Ingelheim, Cohero Health, GSK, Novartis, and ResMed, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global smart inhalers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart inhalers market.

Market Segmentation

• Global Smart Inhalers Market, By Product (Revenue, USD Mn, 2021 - 2033)
• Inhalers
• Metered Dosage Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• Nebulizers
• Global Smart Inhalers Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
• Hospitals
• Pharmacies
• Global Smart Inhalers Market, By Geography (Revenue, USD Mn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Companies Insights
• Adherium Limited
• AstraZeneca
• Boehringer Ingelheim
• Cohero Health
• GSK
• Novartis
• ResMed

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Distribution channel
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in prevalence of respiratory disorders
  • Lack of awareness and high cost of smart inhalers
  • Increasing demand/adoption of smart inhalers
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Smart Inhalers Market, By Type, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Inhalers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
    • Metered Dosage Inhalers (MDIs)
    • Dry Powder Inhalers (DPIs)
• Nebulizers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

5. Global Smart Inhalers Market, By Distribution channel, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)
• Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Mn)

6. Global Smart Inhalers Market, By Geography, 2021 - 2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033 (USD Mn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2021 - 2033,(USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2021 - 2033 (USD Mn)
    • Middle East
    • Africa

7. Competitive Landscape

• Adherium Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cohero Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GSK
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ResMed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us